In focus · trending topic

Phytocannabinoid-Based Therapy

2 stories · following the connections

IGC Announces Third Quarter Financial Results Advances Hyalolex to Commercialization Stage

By Nasdaq OMXFeb 20, 2018, 2:14 PM UTC

IGC Announces Financial Results for Fiscal Year Ended March 31, 2017

By Nasdaq OMXJul 14, 2017, 6:00 AM UTC